Aug 19, 2026 01:58PM
Aug 19, 2026 01:58PM
Jun 29, 2026 04:20PM
Jun 26, 2026 07:00AM
Jun 22, 2026 07:00AM
May 28, 2026 04:01PM
May 28, 2026 04:00PM Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
May 22, 2026 07:01AM
May 22, 2026 07:00AM
May 21, 2026 05:02PM
May 21, 2026 05:01PM
May 18, 2026 03:46PM
May 5, 2026 07:01AM
May 5, 2026 07:00AM Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial
Apr 30, 2026 02:49PM
Apr 29, 2026 04:21PM
Apr 29, 2026 06:30AM
Apr 23, 2026 03:46PM
Apr 23, 2026 03:46PM
Apr 23, 2026 12:53PM
Apr 23, 2026 12:40PM Otarmeni™ (lunsotogene parvec-cwha) Approved by FDA as First and Only Gene Therapy for Genetic Hearing Loss; Regeneron to Provide Otarmeni for Free in the U.S.
Apr 22, 2026 05:30PM
Apr 22, 2026 05:30PM
Apr 21, 2026 10:30AM
Apr 21, 2026 10:30AM
Apr 13, 2026 01:00AM
Apr 8, 2026 08:00AM
Apr 2, 2026 12:01PM FDA approves EYLEA HD for extended dosing up to 20 weeks
Apr 2, 2026 12:00PM
Mar 24, 2026 04:19AM
Mar 24, 2026 02:00AM
Mar 10, 2026 09:29PM
Mar 6, 2026 02:51AM
Mar 3, 2026 05:31PM
Feb 27, 2026 07:13AM Dupixent gets European panel backing for young children with chronic hives
Feb 27, 2026 07:00AM
Feb 24, 2026 09:30AM
Feb 24, 2026 09:30AM
Feb 24, 2026 09:30AM
Feb 19, 2026 07:00AM
Feb 19, 2026 07:00AM
Feb 17, 2026 05:31PM Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight
Feb 16, 2026 05:31PM
Feb 10, 2026 07:00AM
Feb 10, 2026 07:00AM
Feb 9, 2026 07:17AM
Feb 2, 2026 07:00AM
Feb 2, 2026 07:00AM
Dec 23, 2025 04:42AM Japan approves Dupixent for children with severe asthma
Dec 23, 2025 01:00AM

329,068 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All